THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,699,157 | +47.1% | 151,440 | +33.0% | 0.01% | +66.7% |
| Q3 2022 | $1,155,000 | +40.7% | 113,867 | +25.7% | 0.01% | +20.0% |
| Q2 2022 | $821,000 | -44.4% | 90,569 | -41.4% | 0.01% | -58.3% |
| Q1 2022 | $1,477,000 | +59.5% | 154,485 | +84.3% | 0.01% | +33.3% |
| Q4 2021 | $926,000 | +379.8% | 83,822 | +221.4% | 0.01% | +350.0% |
| Q3 2021 | $193,000 | +1.6% | 26,084 | +144.0% | 0.00% | -33.3% |
| Q4 2020 | $190,000 | -70.5% | 10,689 | -65.2% | 0.00% | -72.7% |
| Q2 2020 | $645,000 | -10.4% | 30,751 | +10.6% | 0.01% | -15.4% |
| Q4 2019 | $720,000 | +52.2% | 27,809 | -4.0% | 0.01% | +44.4% |
| Q2 2019 | $473,000 | +56.6% | 28,969 | +117.1% | 0.01% | -10.0% |
| Q1 2019 | $302,000 | +50.2% | 13,342 | +69.8% | 0.01% | +11.1% |
| Q4 2018 | $201,000 | +570.0% | 7,858 | +744.0% | 0.01% | +350.0% |
| Q4 2016 | $30,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |